SPARC plays a complex role in lymphoid malignancies, acting either as a tumor suppressor by inhibiting cell proliferation and inducing apoptosis, or as a tumor promoter by enhancing extracellular matrix (ECM) remodeling, angiogenesis, and immune evasion. Here, SPARC is linked to neoplasm.